BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$3.67B |
| 2 |
S&P Global
SPGI
|
+$3.35B |
| 3 |
Tesla
TSLA
|
+$2.24B |
| 4 |
Microsoft
MSFT
|
+$1.42B |
| 5 |
JPMorgan Chase
JPM
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$4.51B |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$3.67B |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.03B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.49B |
| 5 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.94% |
| 2 | Healthcare | 13.65% |
| 3 | Financials | 12.55% |
| 4 | Consumer Discretionary | 10.62% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCRD
3426
DELISTED
CoreCard
CCRD
| $12.1M | ﹤0.01% |
440,299
-4,833
| -1% | -$164K |
|
|
ME
3427
DELISTED
23andMe Holding Co
ME
| $12M | ﹤0.01% |
156,419
+85,854
| +122% | +$7.84M |
|
3428
The ONE Group
STKS
$56.2M
| $11.9M | ﹤0.01% |
1,135,400
-12,174
| -1% | -$143K |
|
3429
Pliant Therapeutics
PLRX
$64.4M
| $11.9M | ﹤0.01% |
1,698,212
+10,338
| +0.6% | +$105K |
|
3430
Outlook Therapeutics
OTLK
$183M
| $11.9M | ﹤0.01% |
334,006
+38,068
| +13% | +$1.19M |
|
|
OMGA
3431
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $11.9M | ﹤0.01% |
1,905,388
+873,823
| +85% | +$8.92M |
|
|
FUV
3432
DELISTED
Arcimoto, Inc. Common Stock
FUV
| $11.9M | ﹤0.01% |
89,817
-215
| -0.2% | -$27.9K |
|
|
WEBR
3433
DELISTED
Weber Inc.
WEBR
| $11.9M | ﹤0.01% |
1,207,141
+124,712
| +12% | +$1.34M |
|
|
CINC
3434
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $11.9M | ﹤0.01% |
+676,010
| New | +$13.9M |
|
3435
Atossa Therapeutics
ATOS
$20.6M
| $11.8M | ﹤0.01% |
629,136
-6,837
| -1% | -$139K |
|
3436
Sprinklr
CXM
$1.49B
| $11.8M | ﹤0.01% |
990,051
+687,969
| +228% | +$8.3M |
|
|
FLG.PRU
3437
Flagstar Bank National Association Bifurcated Option Note Unit Securities
FLG.PRU
$119M
| $11.8M | ﹤0.01% |
228,060
-17,043
| -7% | -$867K |
|
3438
Q32 Bio
QTTB
$466M
| $11.8M | ﹤0.01% |
214,997
+15,676
| +8% | +$974K |
|
3439
NextDecade
NEXT
$1.79B
| $11.8M | ﹤0.01% |
1,775,191
-5,612
| -0.3% | -$17.6K |
|
|
AMAM
3440
DELISTED
Ambrx Biopharma Inc
AMAM
| $11.7M | ﹤0.01% |
2,851,486
-18,000
| -0.6% | -$92.1K |
|
3441
INNOVATE Corp
VATE
$111M
| $11.7M | ﹤0.01% |
318,029
-4,491
| -1% | -$167K |
|
3442
Hess Midstream
HESM
$5.24B
| $11.7M | ﹤0.01% |
391,128
+268,914
| +220% | +$8.12M |
|
|
TLMD
3443
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
| $11.7M | ﹤0.01% |
3,922,893
-2,576,809
| -40% | -$5.67M |
|
|
FORG
3444
DELISTED
ForgeRock, Inc.
FORG
| $11.7M | ﹤0.01% |
533,081
+122,374
| +30% | +$2.07M |
|
3445
Afya
AFYA
$1.31B
| $11.6M | ﹤0.01% |
807,297
-1,770
| -0.2% | -$24.2K |
|
3446
Cue Biopharma
CUE
$113M
| $11.6M | ﹤0.01% |
79,376
+3,034
| +4% | +$643K |
|
|
SHCR
3447
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $11.6M | ﹤0.01% |
4,705,162
+186,973
| +4% | +$614K |
|
3448
iShares MSCI Hong Kong ETF
EWH
$1.24B
| $11.6M | ﹤0.01% |
512,735
-3,137,071
| -86% | -$73M |
|
3449
Hippo Holdings
HIPO
$830M
| $11.6M | ﹤0.01% |
232,494
+350
| +0.2% | +$18.1K |
|
|
DAWN
3450
DELISTED
Day One Biopharmaceuticals
DAWN
| $11.5M | ﹤0.01% |
1,162,916
+410,797
| +55% | +$5.43M |
|
Similar funds
BlackRock's Q1 2022 Portfolio in Review
As of Q1 2022, BlackRock held 6,014 positions worth $3.71T, down 5.5% from $3.93T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BlackRock's Q1 2022 filing shows 170 new, 2,466 increased, 2,626 reduced and 167 closed positions. Its largest new stake was Constellation Energy: 21,495,337 shares worth $1.21B. The largest sale was Xilinx Inc, an estimated $4.51B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q1 2022 buy was Constellation Energy: 21,495,337 shares worth $1.21B.
- BlackRock added most to Advanced Micro Devices in Q1 2022, an estimated $3.67B increase.
- BlackRock's biggest Q1 2022 reduction was Meta Platforms (Facebook), cutting an estimated $2.03B.
- BlackRock fully exited Xilinx Inc in Q1 2022, selling an estimated $4.51B.
- BlackRock's ten largest holdings make up 21% of its $3.71T portfolio in Q1 2022.
- BlackRock opened 170 new positions and closed 167 in Q1 2022.
- BlackRock's portfolio value fell 5.5% quarter-over-quarter to $3.71T.
Based on BlackRock's 13F filing for Q1 2022, filed 12 May 2022.